Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare ...

FDA Drug Recall #D-1242-2019 — Class III — April 22, 2019

Recall Summary

Recall Number D-1242-2019
Classification Class III — Low risk
Date Initiated April 22, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Zydus Pharmaceuticals USA Inc
Location Pennington, NJ
Product Type Drugs
Quantity 7668 bottles

Product Description

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Reason for Recall

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot #: Z803518, Exp 08/2020

Other Recalls from Zydus Pharmaceuticals USA Inc

Recall # Classification Product Date
D-0834-2020 Class II Ethacrynate Sodium for Injection, USP, 50mg/via... Jan 31, 2020
D-1453-2019 Class II MethylPREDNISolone Tablets, USP 8 mg, 25 tablet... May 6, 2019
D-1441-2019 Class II Anastrozole Tablets, USP, 1 mg, 1,000-count bot... May 6, 2019
D-1448-2019 Class II MethylPREDNISolone Tablets, USP, 4 mg, 100 tabl... May 6, 2019
D-1446-2019 Class II Pramipexole Dihydrochloride Tablets 0.5 mg, 90-... May 6, 2019

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.